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ABSTRACT
Background: Leptin, the product of the obese (ob) gene, is a
regulator of food intake and energy metabolism. Immunoreactive
leptin was detected recently in breast milk and it has been
hypothesized that leptin may be absorbed and may contribute to
differences in body composition between breast-fed and for-
mula-fed infants.
Objective: The objective was to evaluate whether diet, adiposity,
or sex affect plasma leptin in breast-fed and formula-fed infants.
Design: Venous blood samples were drawn from healthy, exclu-
sively breast-fed or formula-fed Swedish infants at 1, 4, and
6 mo of age (n = 193) and from 12-mo-old Finnish infants
(n = 79). Anthropometric measurements were made and plasma
samples were analyzed for leptin, insulin, and glucose.
Results: There were no significant differences in plasma leptin
between formula-fed and breast-fed infants at 1 and 4 mo of age,
whereas formula-fed infants had significantly higher (5%) lep-
tin concentrations at 6 mo of age. Similar results were observed
after correction for BMI. Plasma leptin was 15–25% higher in
female than in male infants at 1, 4, and 12 mo of age (P < 0.05),
also after correction for BMI. When all infants were analyzed
together, a positive correlation (r = 0.34, P < 0.0001) was found
between plasma leptin and BMI. Very low leptin concentrations
were found in breast milk after centrifugation and the high con-
centrations reported previously were likely due to interference in
the assay by milk fat.
Conclusions: Plasma leptin concentrations are not higher in
breast-fed than in formula-fed infants; however, sex and adipos-
ity affect leptin concentrations even at this early age. Am J
Clin Nutr 2000;72:484–9.
KEY WORDS Leptin, infants, milk, formula, breast-feeding,
adiposity, sex
INTRODUCTION
The growth pattern of formula-fed infants has been shown to be
different from that of breast-fed infants (1–4). Most studies
showed that weight gain of the former group is lower than that of
the latter, although not consistently so (5). Weight-for-length
z scores are significantly higher in formula-fed than in breast-fed
infants from 7 to 18 mo of age and the sum of skinfold thicknesses
was significantly higher in formula-fed infants from 5 mo of age,
suggesting that breast-fed infants are leaner (6). The reasons for
the observed differences in body composition are not known,
although it has been speculated that differences in the volume of
milk or formula ingested, the amount of complementary foods
eaten, or the hormonal responses to diet may be involved (4).
Differences in the endocrine response to feeding may con-
tribute to the differences in body composition between formula-
fed and breast-fed infants (7). The endocrine signal may be a
response to the diet fed, such as the difference in serum insulin
concentrations observed between breast-fed and formula-fed
infants (8). It may also be a direct consequence of hormones
being absorbed by breast-fed infants because it is known that
many biologically active hormones are present in human milk (9).
Leptin, a product of the obese gene (ob), is synthesized by
adipocytes and is known to be a regulator of food intake and
energy metabolism (10). Circulating leptin concentrations are
highly correlated with adiposity in adults (11, 12) and children
(13–15) and are markedly elevated in obese individuals (12).
However, adiposity is not the sole determinant of circulating lep-
tin concentrations because plasma leptin decreases after fasting
(16, 17) and energy restriction (18) and increases after refeeding
(16). Circulating leptin concentrations (24 h) are lower when sub-
jects consume high-fat meals than when they consume high-
carbohydrate meals (19). Changes in leptin in response to fasting,
refeeding, and dietary macronutrients are likely to be related to
insulin-mediated glucose metabolism in adipose tissue (20). In
adults, plasma leptin concentrations are higher in women than in
men, even after correction for the higher body fat in women (21).
It is believed that leptin is integral in the feedback loop from
adipose stores to the hypothalamus because leptin administration
decreases food intake in rodents and nonhuman primates and, in
addition, increases energy expenditure in mice and activates the
sympathetic nervous system (22–24). Furthermore, decreases in
leptin during energy restriction in humans are related to
increased sensations of hunger, suggesting that leptin also regu-
lates appetite in humans (25). Recently, immunoreactive leptin
was reported to be present in human milk (26, 27). Concentra-
tions of leptin in milk were lower than in plasma, but were still
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within the range of normal plasma leptin concentrations (26).
The possibility that milk-derived leptin has an effect on infant
growth and metabolism was therefore raised (26, 27).
In the present study, we explored whether plasma leptin con-
centrations in breast-fed and formula-fed infants are different
and whether the body mass index (BMI; in kg/m2) of infants,
regardless of the diet fed, affects circulating leptin concentra-
tions. We further investigated whether the sex differences in
plasma leptin that were observed in children and adults are pres-
ent at this early age.
SUBJECTS AND METHODS
Subjects
We used 2 cohorts of healthy infants in this study: 1) exclu-
sively breast-fed or formula-fed infants at 1, 4, and 6 mo of age
who had participated in a clinical study in Umeå, Sweden (28),
and 2) 12-mo-old infants from a cross-sectional study in Helsinki
(L Lope, B Lönnerdal, unpublished observations, 1996). The for-
mula used was a whey-predominant, powdered, commercially
available product (Baby Semp 2; Semper AB, Stockholm) con-
taining 13 g protein/L. To study the consequences of breast-feed-
ing compared with formula-feeding, these infants were exclu-
sively breast-fed or formula-fed up to 6 mo of age. (In Sweden,
the recommendation is to not introduce solid foods before 6 mo
of age.) Minimal taste portions (< 2 tsp/d, or 10 mL/d) of fruit
purée were allowed between 5 and 6 mo of age, but no other
foods, drinks, or supplements were allowed.
Detailed anthropometric measurements were available from
the data sets from the clinical studies. Sex, weight, length, BMI,
and the number of infants at each age are given in Table 1.
Venous blood samples were drawn 2–3 h postfeeding. Plasma
samples were stored at 80 C until analyzed. The human sub-
jects committees at the 2 sites approved the respective studies
and informed consent was obtained.
Assays
Plasma leptin was measured by radioimmunoassay (Linco
Research, St Louis) (29), as was insulin (30); glucose was meas-
ured with a glucose analyzer (model 2300; Yellow Springs
Instruments, Yellow Springs, OH). Human milk was obtained
from healthy women in midlactation (2–4 mo) and was stored
frozen. Whole milk and skim milk were centrifuged at 1100  g
for 30 min at 4 C and samples were assayed for leptin by using
the plasma leptin assay. We added 100 g human leptin/L to the
samples to study the recovery of leptin. We also added Intralipid
(Baxter, Deerfield, IL) or cow milk fat to human skim milk sam-
ples to obtain a fat concentration similar to that of whole human
milk (4%) to study the possible interference of lipids.
Statistical analyses
The statistics package STATVIEW (Abacus Concepts, Inc,
Berkeley, CA) was used for linear regression analysis. Unpaired
t tests were used for comparisons between male and female
infants and between breast-fed and formula-fed infants. Multi-
variate statistical models were also used to analyze the data.
Results are expressed as means ± SEMs. Statistical significance
was set at P < 0.05.
RESULTS
There were no significant differences in birth weight between
the breast-fed and formula-fed infants (Table 2). Breast-fed
infants weighed more did than formula-fed infants at all ages, but
the BMI was higher in breast-fed than in formula-fed infants only
at 1 mo of age. Concentrations of absolute and adiposity-corrected
plasma leptin, plasma insulin, and plasma glucose are also given
in Table 2. There were no significant differences in plasma leptin
concentrations between formula-fed and breast-fed infants at 1
and 4 mo of age, whereas formula-fed infants had slightly, but
significantly, higher leptin concentrations at 6 mo of age. Similar
results were obtained after correction for adiposity (BMI). Insulin
concentrations were higher (P < 0.03) in breast-fed than in formula-
fed infants at 1 mo of age, but at 4 and 6 mo of age, formula-fed
infants had considerably higher concentrations than did breast-fed
infants. Insulin-glucose ratios were significantly higher in for-
mula-fed than in breast-fed infants at 4 mo of age.
Male infants weighed more than did female infants at 4, 6, and
12 mo of age, whereas BMI was similar in male and female
infants at all ages. Plasma leptin concentrations were signifi-
cantly higher in female than in male infants at 1, 4, and 12 mo of
age, whereas no significant difference was found at 6 mo of age
(Table 3). In an analysis of all infants, regardless of age, girls
had significantly higher plasma leptin concentrations than boys
(P < 0.003). This difference remained after correction for adi-
posity (leptin:BMI) (P < 0.002). The plasma insulin concentra-
tion (P < 0.03) and the insulin-glucose ratio (P < 0.02) were
significantly higher in boys than in girls at 6 mo of age.
Plasma leptin concentrations were significantly correlated
with BMI when all infants were analyzed, regardless of age, sex,
or diet group (Figure 1). There was no significant correlation
between plasma leptin and plasma insulin concentrations or
between plasma leptin and plasma glucose concentrations (Fig-
ure 2). Surprisingly, plasma insulin was marginally, but nega-
tively, correlated with BMI (r = 0.15, P < 0.03).
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TABLE 1
Characteristics of study infants1
Boys Girls
1 mo 4 mo 6 mo 12 mo 1 mo 4 mo 6 mo 12 mo
(n = 29) (n = 33) (n = 33) (n = 39) (n = 29) (n = 35) (n = 34) (n = 40)
Weight (kg) 4.45 ± 0.14 7.01 ± 0.13 8.08 ± 0.15 10.56 ± 0.17 4.27 ± 0.11 6.49 ± 0.142 7.56 ± 0.163 10.06 ± 0.224
Length (m) 0.55 ± 0.01 0.64 ± 0.01 0.68 ± 0.01 0.78 ± 0.01 0.54 ± 0.01 0.63 ± 0.01 0.67 ± 0.01 0.76 ± 0.01
BMI (kg/m2) 14.6 ± 0.3 16.8 ± 0.2 17.3 ± 0.2 17.4 ± 0.2 14.4 ± 0.2 16.3 ± 0.2 17.0 ± 0.3 17.3 ± 0.2
1 x– ± SEM.
2–4 Significantly different from boys at a given age (unpaired t test): 2 P < 0.005, 3 P < 0.02, 4 P < 0.05.
In a multiple regression analysis, formula feeding was found
to be a significant predictor of only leptin at 6 mo of age, which
was 15% higher in formula-fed infants.
Insulin was not a predictor of leptin in a multiple regression
analysis either in the 1–6-mo data set or in all infants ≤12 mo
of age. In the 1–6-mo data set, only BMI (P < 0.0001), sex
(P < 0.005), and age (P < 0.01) were independent predictors of
leptin in a multiple regression analysis including diet, BMI,
insulin, glucose, sex, and age. In the 1–12-mo data set, only BMI
(P < 0.0001) and sex (P < 0.002) were independent predictors of
leptin in a multiple regression analysis including BMI, insulin,
glucose, sex, and age, but not diet (because the 12-mo-olds were
consuming varied diets). Values were normally distributed and
log transformation did not affect any of our conclusions.
Earlier reports suggested relatively high concentrations of lep-
tin in human milk. Our first assay results also indicated leptin
concentrations in human milk that were high enough to be con-
sidered of potential physiologic relevance. However, results after
centrifugation suggested either that the leptin segregated with
the lipid fraction of the milk or that milk fat interfered with the
assay method and that the measured values were an artifact. As
suggested by the assay manufacturer, 100 g human leptin/L
was added to 4 pools of human milk. Samples for leptin assay
were collected before, immediately after, and 24 h after addition
of human leptin. Because we suspected interference by lipids,
we also centrifuged the milk at 1100  g for 30 min at 4 C
(“skimming”) and at 12 000  g for 30 min at 4 C (high-speed
centrifugation). As shown in Table 4, whole human milk
appeared to contain 13.3–74.4 g leptin/L. Addition of human
leptin to the samples did not lead to any significant increase in
the leptin concentration of whole milk. However, when leptin
was added to defatted milk, nearly all of the added leptin was
recovered, although the assayed values did decrease after 24 h of
additional incubation. It therefore appears that lipids in human
milk interfere with the leptin assay and that actual leptin con-
centrations are relatively low. This finding was also supported by
the observation that rat milk appeared to contain substantial
concentrations of human leptin when assayed with the human
antiserum (Linco), which does not cross-react with rat leptin. In
contrast, defatted milk samples from this species contained very
low or undetectable amounts of leptin when measured with the
human leptin assay. When lipids were added to human skim milk
in the form of Intralipid or cow milk fat (neither containing
human leptin), the measured leptin concentrations increased sub-
stantially, which also suggests lipid interference with the assay.
DISCUSSION
The leptin concentrations we found in infant plasma were
similar to those of the 5–9-y-old children in the study by Garcia-
Mayor et al (15). Male infants had mean leptin concentrations of
4 g/L, whereas female infants had significantly higher con-
centrations (5.5 g/L). Thus, during the first year of life, sex
differences in circulating leptin concentrations are already
apparent, although the differences are not as great as those
observed in adults. A recent study by Jaquet et al (31) suggested
that there are sex differences in serum leptin concentrations in
human fetuses (37 wk of gestation) and in newborns, although
these differences are not significant. Helland et al (32) found
recently that there are sex differences in leptin concentrations in
umbilical cord plasma (10.8 and 7.6 g/L in girls and boys,
respectively) and at 0.5 mo of age (3.9 and 3.2 g/L in girls and
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TABLE 2
Effect of diet on morphometric indexes and absolute and adiposity-corrected plasma leptin and insulin and glucose in infants1
Formula-fed Breast-fed
Birth 1 mo 4 mo 6 mo Birth 1 mo 4 mo 6 mo
(n = 38) (n = 30) (n = 38) (n = 38) (n = 31) (n = 31) (n = 31) (n = 30)
Weight (kg) 3.43 ± 0.09 4.11 ± 0.15 6.55 ± 0.12 7.61 ± 0.16 3.54 ± 0.09 4.55 ± 0.122 6.95 ± 0.153 8.02 ± 0.163
BMI (kg/m2) — 14.1 ± 0.2 16.5 ± 0.2 17.0 ± 0.2 — 14.9 ± 0.23 16.7 ± 0.3 17.3 ± 0.3
Leptin (g/L) — 4.4 ± 0.3 5.0 ± 0.2 5.1 ± 0.3 — 5.0 ± 0.4 5.6 ± 0.4 4.4 ± 0.23
Leptin:BMI — 0.31 ± 0.02 0.30 ± 0.01 0.30 ± 0.02 — 0.34 ± 0.03 0.31 ± 0.03 0.25 ± 0.013
Insulin (pmol/L) — 99.6 ± 13.8 135.0 ± 15.0 96.6 ± 12.6 — 155.4 ± 29.43 60.6 ± 10.24 69.6 ± 19.2
Glucose (mmol/L) — 4.4 ± 0.1 4.7 ± 0.1 4.5 ± 0.2 — 4.4 ± 0.1 4.0 ± 0.24 4.7 ± 0.2
Insulin:glucose — 21.6 ± 2.2 28.1 ± 2.2 20.5 ± 2.2 — 34.6 ± 6.53 15.1 ± 2.24 13.0 ± 3.23
1 x– ± SEM.
2–4 Significantly different from formula-fed infants at a given age (unpaired t test): 2 P < 0.01, 3 P < 0.05, 4 P < 0.001.
TABLE 3
Effect of sex on absolute and adiposity-corrected plasma leptin and insulin and glucose in infants1
Boys Girls
1 mo 4 mo 6 mo 12 mo 1 mo 4 mo 6 mo 12 mo
(n = 29) (n = 33) (n = 33) (n = 39) (n = 29) (n = 35) (n = 35) (n = 40)
Leptin (g/L) 4.6 ± 0.3 4.5 ± 0.3 4.8 ± 0.3 5.0 ± 0.2 5.8 ± 0.32 5.4 ± 0.32 4.8 ± 0.3 5.7 ± 0.33
Leptin:BMI 0.28 ± 0.02 0.27 ± 0.01 0.27 ± 0.02 0.28 ± 0.01 0.36 ± 0.033 0.35 ± 0.022 0.28 ± 0.02 0.33 ± 0.013
Insulin (pmol/L) 141.0 ± 30.6 111.6 ± 15.0 108.6 ± 18.6 90.0 ± 9.0 109.8 ± 12.0 107.4 ± 17.4 67.8 ± 10.83 41.4 ± 9.6
Glucose (mmol/L) 4.4 ± 0.1 4.6 ± 0.2 4.7 ± 0.29 3.9 ± 0.1 4.4 ± 0.2 4.4 ± 0.1 4.5 ± 0.1 3.7 ± 0.13
Insulin:glucose 31.3 ± 6.5 23.8 ± 2.2 21.6 ± 3.2 8.6 ± 1.1 24.8 ± 2.2 23.8 ± 3.2 14.0 ± 2.23 10.8 ± 2.2
1 x– ± SEM.
2,3 Significantly different from boys at a given age (unpaired t test): 2 P < 0.01, 3 P < 0.05.
boys, respectively). Taken together, these observations suggest
that sex differences are apparent very early postnatally.
Serum leptin concentrations were examined previously in new-
borns (31–33), children (14, 15), adolescents (13, 15), and adults
(11, 12, 18, 21). In males, serum leptin concentrations increased
between the ages of 5 and 10 y, decreased from 10 to 15 y (15),
and then increased very modestly to reach adult concentrations of
3.5 g/L in normal-weight men (21). The decrease observed
between 10 and 15 y of age correlated with the increased testos-
terone concentrations concomitant with the onset of puberty (15).
The prepubertal and pubertal rise in leptin concentrations in
young females was found to correlate with increases in serum
follicle-stimulating hormone, luteinizing hormone, and estra-
diol (15). However, plasma leptin concentrations are not signi-
ficantly different between premenopausal and postmenopausal
women or between postmenopausal women receiving and not
receiving hormone replacement therapy (10). Therefore, normal
concentrations of female reproductive hormones do not appear
to be important determinants of circulating leptin concentra-
tions in adult women. Furthermore, in adults, the sex difference
in circulating leptin concentrations cannot be explained by
increased adipose mass in women (10). Because overall body
adiposity and fat distribution are not significantly different
between male and female infants, and because the hormonal
profile of male and female infants is unlikely to be different at
this young age, the reason for the sex difference in serum leptin
concentrations in infants remains unknown.
Serum leptin concentrations were not significantly higher in
breast-fed than in formula-fed infants; at 1 and 4 mo of age
there was no significant difference between the groups and at
6 mo of age, breast-fed infants had significantly lower serum
leptin concentrations. This difference remained after correction
for adiposity (leptin:BMI). Thus, it appears unlikely that leptin
in breast milk is absorbed in physiologically relevant amounts,
which, in turn, would contribute to differences in growth and
body composition in late infancy. If there was an effect on body
composition of exogenous leptin from breast milk, differences
in serum leptin between the breast-fed and formula-fed groups
would have been expected at 4 and 6 mo of age because body fat
(sum of skinfold thicknesses) is significantly different at 5 mo
of age and weight-for-height is significantly different at 7 mo of
age between these 2 groups (6). Dietary macronutrient compo-
sition was shown to influence circulating leptin concentrations
over a 24-h period in adults (19). Whether this also occurs in
infants is not known; however, the percentage of the diet being
provided as fat and carbohydrate in our study was similar in
breast-fed and formula-fed infants and, therefore, it was
unlikely to have affected leptin concentrations.
We found that the breast-fed infants had significantly higher
body weights than did the formula-fed infants at 1, 4, and 6 mo of
age. This was most likely due to the initially higher weights of the
breast-fed infants at 1 mo of age. We believe that this was a coin-
cidence because the infants could not be randomly assigned to
groups for ethical reasons. As can be seen in Table 3, weight gain
between 1 and 4 mo and between 4 and 6 mo of age was similar
in the 2 groups. In our previous longitudinal study of growth and
body composition of infants (the DARLING study), several of the
skinfold-thickness measurements of breast-fed infants tended to
be higher than those of formula-fed infants at 1 mo of age,
although not significantly so (6). Two recent studies (31, 33)
showed that serum leptin concentrations in newborns are 2 g/L,
which is considerably lower than the concentrations we found at
1 mo of age. Serum leptin concentrations are also lower than those
reported as 0.5 mo of age (32). Therefore, it appears that serum
leptin concentrations increase significantly during the first weeks
of life, most likely as a consequence of the early postnatal gain in
adipose tissue. Marchini et al (33) showed that serum leptin
decreased by 26% during the first 4 d after birth, which was
associated with a 3–6% weight reduction. A subsequent rapid
weight gain is likely to result in increased adipose tissue.
There appear to be analytic problems associated with meas-
uring leptin in whole milk with a radioimmunoassay routinely
used for measuring serum and plasma leptin concentrations.
This interference by milk fat is likely to explain some previous
reports of high leptin concentrations in milk. Skimming of the
breast milk led to analyzed leptin concentrations in breast milk
of < 0.5 g/L, which is considerably lower than those reported
by Houseknecht et al (26). These authors reported that whole
breast milk contained 10.1 ± 2.6 g/L, whereas one of their
figures clearly showed that most of their whole milk samples
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FIGURE 1. Correlation between plasma leptin concentrations and
body mass index (BMI) in all infants.
FIGURE 2. Correlation between plasma leptin and plasma insulin
concentrations in all infants.
contained ≤1 g leptin/L. Similarly, they reported a leptin
concentration in skim milk of 1.5 ± 0.8 g/L, whereas the
same figure showed that most analyzed values were 0.5 g/L
and that several samples contained no detectable leptin.
Although we did not extensively analyze leptin in breast milk,
the values reported for skim milk by Houseknecht et al (26) are
similar to those that we found. Because these values are 10-
fold lower than serum leptin concentrations in infants, it is
unlikely that they would contribute significantly to circulating
serum leptin concentrations (30).
A recent study by Smith-Kirwin et al (34) showed that human
mammary epithelial cells express leptin and that they are the
likely origin of leptin in breast milk. These researchers found
concentrations of leptin in skim milk that were similar to those
in our study, but found considerably higher concentrations in
whole milk that had been sonicated. We attempted to use this
method but consistently experienced interference by milk fat in
the assay, giving what we believe were artificially elevated val-
ues. Furthermore, our observation that adding rat milk to the
human leptin assay yielded high leptin concentrations (but leptin
from this species does not cross-react with this antibody) and
that addition of Intralipid or cow milk fat to human skim milk
samples resulted in high milk leptin concentrations strongly sug-
gests interference by fat in the assay. It is therefore evident that
further work is needed to best determine how to accurately
assess leptin concentrations in whole milk.
The breast-fed infants had significantly lower plasma insulin
concentrations than did the formula-fed infants at 4 mo of age.
This was reported earlier and it is believed to have been due to a
considerably higher protein intake in the formula-fed infants (8).
Despite the higher plasma insulin concentrations in the formula-
fed than in the breast-fed infants, plasma glucose concentrations
were significantly higher in the formula-fed than in the breast-
fed infants at the same age. This suggests some insulin resistance
in the formula-fed infants. Unlike in adults, we found no signifi-
cant correlation between plasma leptin and plasma insulin con-
centrations. One possible explanation for this lack of correlation
is the relative homogeneity of serum leptin concentrations in
infants. Serum leptin ranged from only 2 to 12 g/L, whereas
in most studies in adults in which correlations between insulin
and leptin were reported, the range of circulating leptin concen-
trations was much wider, eg, 5–70 g/L in one study (20). Fur-
thermore, much of the relation between leptin and insulin is due
to their correlations with adiposity, such that the relation
between leptin and insulin is not always significant indepen-
dently of variations in BMI and adiposity (20). In the present
study, no positive relation between BMI and insulin was
observed. However, a time-course study examining circulating
leptin over time in relation to insulin responses to feeding (19)
would likely provide more relevant information on insulin-leptin
relations in this population.
In summary, circulating leptin concentrations are not higher in
breast-fed than in formula-fed infants. Serum leptin concentra-
tions are higher in female than in male infants and are signifi-
cantly related to BMI, but not to serum insulin. Thus, a small but
significant sex difference and a relation with adiposity are
already present in young infants.
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